{"id":4371,"date":"2025-02-05T10:51:14","date_gmt":"2025-02-04T23:51:14","guid":{"rendered":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/medicinal-marijuana-mayhem-the-cowboy-culture-of-regressive-vote-for-medicine-framework\/"},"modified":"2025-11-12T21:00:25","modified_gmt":"2025-11-12T10:00:25","slug":"medicinal-marijuana-mayhem-the-cowboy-culture-of-regressive-vote-for-medicine-framework","status":"publish","type":"post","link":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/medicinal-marijuana-mayhem-the-cowboy-culture-of-regressive-vote-for-medicine-framework\/","title":{"rendered":"Medicinal Marijuana Mayhem: The Cowboy Culture of Regressive Vote for Medicine Framework"},"content":{"rendered":"
<\/header>\n
\n
\n
\n

Australia\u2019s medicinal cannabis industry is experiencing unprecedented growth, but at what cost to public health and medical standards? As state governments rush to establish new cannabis facilities and prescription rates soar to record heights, medical experts are sounding increasingly urgent alarms about a system veering dangerously off course. What began as a carefully controlled therapeutic option has morphed into what industry insiders now describe as the \u201cWild West of medicine\u201d \u2013 a landscape where regulatory oversight struggles to keep pace with commercial interests, and where social media advocacy often carries more weight than clinical evidence. The transformation of Australia\u2019s medical cannabis framework from cautious experimentation to mass prescription raises profound questions about the intersection of public demand, commercial opportunity, and medical responsibility.<\/span><\/p>\n

The Marketing Masquerade<\/strong><\/span><\/h2>\n

\"MedicinalCannabisDoesntWork\"<\/p>\n

The headlines practically write themselves these days: \u201cMedicinal cannabis supply to reach new high\u201d \u2013 an unintentional double entendre that would be amusing if it weren\u2019t so telling of our current predicament. State governments are falling over themselves to establish cannabis facilities, despite GW Pharma in England having already invested a decade in properly clinical trials for their epilepsy medicine.<\/span><\/p>\n

The numbers tell a story of explosive, arguably reckless growth. From serving a mere 18,000 patients in 2019, the industry now claims over one million patients as of January 2024. In just the first half of 2024, Australians spent an eye-watering $402 million on medicinal cannabis prescriptions \u2013 nearly matching 2023\u2019s entire total of $448 million. Unit sales have skyrocketed to 2.87 million in just six months, leaving 2023\u2019s 1.68 million figure in the dust.<\/span><\/p>\n

The media\u2019s handling of this issue would be comical if it weren\u2019t so concerning. Take Channel 7\u2019s coverage, where personal anecdotes and \u201csocial commentators\u201d \u2013 not medical experts \u2013 hold court on medical science. The formula is predictable: throw in a tear-jerking personal story, add some anti-\u201cbig pharma\u201d sentiment, and top it off with the timeless appeal to parental instinct: \u201cParents know what\u2019s best for their children.\u201d Science? That\u2019s apparently optional.<\/span><\/p>\n

The Thalidomide Echo<\/strong><\/span><\/h2>\n

Those who cannot remember the past are condemned to repeat it, and Australia\u2019s medical history offers a stark warning. The Thalidomide disaster of the 1960s \u2013 which Australia could have avoided by following the FDA\u2019s cautious approach \u2013 seems to have taught us little. While the United States saw fewer than 50 cases of birth defects, Australia\u2019s more permissive approach led to thousands of casualties. Yet here we are again, watching history rhyme as regulatory caution gives way to commercial expedience.<\/span><\/p>\n

The statistical explosion in prescriptions is staggering. Only two medicinal cannabis products have actually been evaluated for safety and efficacy by the TGA, yet we have over 800 different products flooding the market. In one particularly egregious case, a single doctor prescribed cannabis to 12,000 patients in just six months \u2013 a volume that should raise red flags visible from orbit.<\/span><\/p>\n

The Vertical Integration Virus<\/strong><\/span><\/h2>\n

Perhaps the most insidious aspect of this new frontier is the rise of vertically integrated clinics owned by cannabis suppliers. It\u2019s a conflict of interest so obvious it barely needs stating, yet it flourishes in plain sight. As one experienced prescriber noted, \u201cThe industry has a serious conflict of interest problem with clinics being owned by suppliers, which is rampant, and zero transparency about that.\u201d<\/span><\/p>\n

While the industry celebrates its financial success, the human cost mounts. Health authorities report 461 patients diagnosed with mental and behavioral disorders due to cannabinoid use and psychotic disorder in 2022-23 \u2013 a 23% increase from 2019-20. Yet these statistics barely register in the rush to expand access.<\/span><\/p>\n

The Regulatory Retreat<\/strong><\/span><\/h2>\n

The TGA\u2019s position is particularly telling. Under \u201cAccessing Unapproved Products,\u201d they\u2019ve created a new category for cannabis that essentially admits defeat: prescribers and dispensers know little about medicinal cannabis because there\u2019s been minimal research and even less education about it in medical training. Yet somehow, this acknowledgment of ignorance serves as a basis for expanded access rather than increased caution.<\/span><\/p>\n

Victoria\u2019s early adoption serves as a cautionary tale. Their taxpayer-funded program saw more than one-third of child patients drop out when the treatment proved ineffective \u2013 right as properly trialed alternatives like Epidiolex were receiving FDA approval through conventional clinical testing. But why let evidence get in the way of a good story?<\/span><\/p>\n

The medical community finds itself divided. Many doctors keep their cannabis prescribing quiet, facing skepticism from colleagues who dare to ask for evidence. Meanwhile, the industry pushes forward, armed with testimonials and backed by a chorus of social media support.<\/span><\/p>\n

The Way Forward?<\/strong><\/span><\/h2>\n

Associate Professor Vicki Kotsirilos, Australia\u2019s first authorised GP prescriber, advocates for returning control to primary care physicians who know their patients\u2019 histories and can properly assess risks. But in a system where profit drives policy and anecdotes outweigh evidence, such voices of reason struggle to be heard.<\/span><\/p>\n

As we watch this experiment unfold, one thing becomes clear: we\u2019re witnessing a massive public health experiment in real-time, with minimal controls and maximum profit potential. The parallels to both the Thalidomide disaster and Big Tobacco\u2019s playbook are impossible to ignore, yet we march forward, eyes wide shut to the lessons of history.<\/span><\/p>\n

Only time will reveal the full cost of our haste, but if history is any guide, the bill will be steep, and it won\u2019t be the industry picking up the tab. (Source: WRD News<\/strong><\/a>)<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Australia\u2019s medicinal cannabis industry is experiencing unprecedented growth, but at what cost to public health and medical standards? As state governments rush to establish new cannabis facilities and prescription rates soar to record heights, medical experts are sounding increasingly urgent alarms about a system veering dangerously off course. What began as a carefully controlled therapeutic […]<\/p>\n","protected":false},"author":2,"featured_media":4370,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":"","_wp_rev_ctl_limit":""},"categories":[15],"tags":[77],"class_list":["post-4371","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cannabis-as-medicine","tag-cannabis-as-medicine"],"_links":{"self":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/posts\/4371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/comments?post=4371"}],"version-history":[{"count":0,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/posts\/4371\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/media\/4370"}],"wp:attachment":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/media?parent=4371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/categories?post=4371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/tags?post=4371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}